-+ 0.00%
-+ 0.00%
-+ 0.00%

Theriva Biologics Q3 EPS $(0.45) Beats $(1.13) Estimate

Benzinga·11/12/2025 13:14:03
Listen to the news
Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(1.13) by 60.18 percent. This is a 93.39 percent increase over losses of $(6.81) per share from the same period last year.